IMPACT OF GLP-1 AGONISTS AND SOCIAL DETERMINANTS OF HEALTH ON OUTCOMES FOLLOWING TOTAL KNEE ARTHROPLASTY
Glucagon-like peptide (GLP)-1 agonists are increasingly used for type 2 diabetes and obesity management. Access to GLP-1 medications remains difficult for patients, especially those with low socioeconomic status. GLP-1s have been demonstrated to be predictors of positive outcomes following total knee arthroplasty (...